ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.89
+10.65%Forward multiples
Based on analyst estimates
- P/E forward
- 37.18x
- P/E 2026E
- 65.58x
- P/E 2027E
- 25.27x
- P/E 2028E
- 16.07x
- P/S forward
- 6.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- 144.43x
- PEG TTM
- 0.50x
- Price / book
- 18.17x
- Price / sales
- 8.64x
- Price / cash flow
- 101.97x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 8.37x
- EV / EBITDA
- 89.43x
- EV / EBIT
- 113.39x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026